 BOSTON, Jan. 22, 2021 PRNewswire -- Haemonetics Corporation NYSE: HAE Haemonetics, a global medical technology company focused on delivering innovative medical solutions to drive better patient outcomes, affirms its support of new guidance issued by the U.S. Food and Drug... 